Track the 엔케이젠바이오텍코리아 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엔케이젠바이오텍코리아 has recorded 51 public disclosures. The latest transaction was reported on 10 July 2025 (Purchase). Among the most active insiders: 박근호. All data is free.
51
Insider Decl.
n/a
Thresholds
n/a
34 ops.
Buy Volume
n/a
4 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
NK Gen Biotech Korea es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones biofarmacéuticas.